A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery

Ou Wang, Ayman Ismail, Frank Marco Fabian, Haishuang Lin, Qiang Li, Christian Elowsky, Mark Alan Carlson, Wilson Burgess, William H Velander, Srivatsan S Kidambi, Yuguo Lei

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Mesenchymal stem cells (MSCs) have been widely studied for tissue engineering and treating diseases in laboratories, clinical trials, and clinics. Fibrin matrices are often used to culture MSCs or increase the retention of MSCs at the injection site. However, fibrins made with the human plasma derived fibrinogen have high cost and risk of human pathogen transmission. In this article, we studied if fibrin matrices made with recombinant human fibrinogen, recombinant human thrombin, and recombinant human factor XIII could be used to culture and deliver MSCs. We systematically investigated the relationships between the fibrin matrix formulation, its nanostructure, and the behaviors of the cells in the matrix including the cell morphology, viability, and growth. We found that the fibrinogen concentration significantly affected the matrix structure and cell behaviors. We then used an optimized fibrin matrix to deliver human MSCs into mice subcutaneously. We found that the matrix could significantly enhance the retention of MSCs at the injection site. To our best knowledge, this is the first study on using fibrin matrices made with entirely recombinant proteins for culturing and delivering MSCs.

Original languageEnglish (US)
Pages (from-to)3135-3142
Number of pages8
JournalJournal of Biomedical Materials Research - Part A
Volume106
Issue number12
DOIs
StatePublished - Dec 2018

Fingerprint

Stem cells
Fibrin
Cell culture
Fibrinogen
Clinical laboratories
Plasma (human)
Factor XIII
Recombinant proteins
Pathogens
Human engineering
Tissue engineering
Recombinant Proteins
Nanostructures
Cells
Costs

Keywords

  • cell culture
  • cell delivery
  • mesenchymal stem cells
  • recombinant fibrin matrix

ASJC Scopus subject areas

  • Ceramics and Composites
  • Biomaterials
  • Biomedical Engineering
  • Metals and Alloys

Cite this

A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery. / Wang, Ou; Ismail, Ayman; Fabian, Frank Marco; Lin, Haishuang; Li, Qiang; Elowsky, Christian; Carlson, Mark Alan; Burgess, Wilson; Velander, William H; Kidambi, Srivatsan S; Lei, Yuguo.

In: Journal of Biomedical Materials Research - Part A, Vol. 106, No. 12, 12.2018, p. 3135-3142.

Research output: Contribution to journalArticle

Wang, Ou ; Ismail, Ayman ; Fabian, Frank Marco ; Lin, Haishuang ; Li, Qiang ; Elowsky, Christian ; Carlson, Mark Alan ; Burgess, Wilson ; Velander, William H ; Kidambi, Srivatsan S ; Lei, Yuguo. / A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery. In: Journal of Biomedical Materials Research - Part A. 2018 ; Vol. 106, No. 12. pp. 3135-3142.
@article{76df8e00f4f4414f82c372ad02aa3406,
title = "A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery",
abstract = "Mesenchymal stem cells (MSCs) have been widely studied for tissue engineering and treating diseases in laboratories, clinical trials, and clinics. Fibrin matrices are often used to culture MSCs or increase the retention of MSCs at the injection site. However, fibrins made with the human plasma derived fibrinogen have high cost and risk of human pathogen transmission. In this article, we studied if fibrin matrices made with recombinant human fibrinogen, recombinant human thrombin, and recombinant human factor XIII could be used to culture and deliver MSCs. We systematically investigated the relationships between the fibrin matrix formulation, its nanostructure, and the behaviors of the cells in the matrix including the cell morphology, viability, and growth. We found that the fibrinogen concentration significantly affected the matrix structure and cell behaviors. We then used an optimized fibrin matrix to deliver human MSCs into mice subcutaneously. We found that the matrix could significantly enhance the retention of MSCs at the injection site. To our best knowledge, this is the first study on using fibrin matrices made with entirely recombinant proteins for culturing and delivering MSCs.",
keywords = "cell culture, cell delivery, mesenchymal stem cells, recombinant fibrin matrix",
author = "Ou Wang and Ayman Ismail and Fabian, {Frank Marco} and Haishuang Lin and Qiang Li and Christian Elowsky and Carlson, {Mark Alan} and Wilson Burgess and Velander, {William H} and Kidambi, {Srivatsan S} and Yuguo Lei",
year = "2018",
month = "12",
doi = "10.1002/jbm.a.36508",
language = "English (US)",
volume = "106",
pages = "3135--3142",
journal = "Journal of Biomedical Materials Research",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery

AU - Wang, Ou

AU - Ismail, Ayman

AU - Fabian, Frank Marco

AU - Lin, Haishuang

AU - Li, Qiang

AU - Elowsky, Christian

AU - Carlson, Mark Alan

AU - Burgess, Wilson

AU - Velander, William H

AU - Kidambi, Srivatsan S

AU - Lei, Yuguo

PY - 2018/12

Y1 - 2018/12

N2 - Mesenchymal stem cells (MSCs) have been widely studied for tissue engineering and treating diseases in laboratories, clinical trials, and clinics. Fibrin matrices are often used to culture MSCs or increase the retention of MSCs at the injection site. However, fibrins made with the human plasma derived fibrinogen have high cost and risk of human pathogen transmission. In this article, we studied if fibrin matrices made with recombinant human fibrinogen, recombinant human thrombin, and recombinant human factor XIII could be used to culture and deliver MSCs. We systematically investigated the relationships between the fibrin matrix formulation, its nanostructure, and the behaviors of the cells in the matrix including the cell morphology, viability, and growth. We found that the fibrinogen concentration significantly affected the matrix structure and cell behaviors. We then used an optimized fibrin matrix to deliver human MSCs into mice subcutaneously. We found that the matrix could significantly enhance the retention of MSCs at the injection site. To our best knowledge, this is the first study on using fibrin matrices made with entirely recombinant proteins for culturing and delivering MSCs.

AB - Mesenchymal stem cells (MSCs) have been widely studied for tissue engineering and treating diseases in laboratories, clinical trials, and clinics. Fibrin matrices are often used to culture MSCs or increase the retention of MSCs at the injection site. However, fibrins made with the human plasma derived fibrinogen have high cost and risk of human pathogen transmission. In this article, we studied if fibrin matrices made with recombinant human fibrinogen, recombinant human thrombin, and recombinant human factor XIII could be used to culture and deliver MSCs. We systematically investigated the relationships between the fibrin matrix formulation, its nanostructure, and the behaviors of the cells in the matrix including the cell morphology, viability, and growth. We found that the fibrinogen concentration significantly affected the matrix structure and cell behaviors. We then used an optimized fibrin matrix to deliver human MSCs into mice subcutaneously. We found that the matrix could significantly enhance the retention of MSCs at the injection site. To our best knowledge, this is the first study on using fibrin matrices made with entirely recombinant proteins for culturing and delivering MSCs.

KW - cell culture

KW - cell delivery

KW - mesenchymal stem cells

KW - recombinant fibrin matrix

UR - http://www.scopus.com/inward/record.url?scp=85052468507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052468507&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.36508

DO - 10.1002/jbm.a.36508

M3 - Article

C2 - 30152030

AN - SCOPUS:85052468507

VL - 106

SP - 3135

EP - 3142

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 1549-3296

IS - 12

ER -